LENZ Therapeutics (LENZ) Other Non Operating Income (2021 - 2026)

LENZ Therapeutics (LENZ) has 6 years of Other Non Operating Income data on file, last reported at $3000.0 in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 127.27% year-over-year to $3000.0 in Q1 2026; TTM through Mar 2026 was -$229000.0, a 114.08% decrease from a year earlier, with the FY2025 full-year figure at -$243000.0, down 184.08% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $3000.0, up from -$417000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for LENZ reached as high as $2.2 million in Q4 2022 and fell as low as -$1.3 million in Q1 2024.
• Historically, Other Non Operating Income has averaged $278235.3 across 5 years, with a median of $3000.0 in 2026.
• Across the five-year window, Other Non Operating Income soared 21420.0% in 2022 and tumbled 5312.5% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $2.2 million in 2022, then plunged by 87.59% to $267000.0 in 2023, then slumped by 97.0% to $8000.0 in 2024, then tumbled by 5312.5% to -$417000.0 in 2025, then surged by 100.72% to $3000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $3000.0 in Q1 2026, -$417000.0 in Q4 2025, and -$14000.0 in Q3 2025.